Among patients with stage III NSCLCs (Figure 3F, right panel), those with higher UBL3 had slightly but not statistically significantly shorter OS than those with lower expression of UBL3. The expression of UBL3 was significantly higher in female NSCLC patients than in male NSCLC patients in TCGA dataset (Figure 3G). This evidence concerns the gene UBL3 and non-small cell lung carcinoma.